Richard Engh

Title: The Innovative Contributions of Richard Engh

Introduction

Richard Engh is a notable inventor based in Tromsoe, Norway. He has made significant contributions to the field of biotechnology, holding a total of 10 patents. His work focuses on the development of novel compounds and polypeptides that have potential applications in pharmaceuticals.

Latest Patents

One of Engh's latest patents is the "Serpin-finger fusion polypeptide." This invention comprises a fusion polypeptide that includes a serpin-finger polypeptide conjugated to a biologically active polypeptide, optionally via a peptidic linker polypeptide. Another aspect of this invention involves a protein complex of the serpin-finger fusion polypeptide and a serpin, where the fusion polypeptide is incorporated into the serpin within the middle of beta-sheet A as strand 4a. Additionally, the invention covers the in vitro preparation of this protein complex, highlighting the serpin-finger polypeptide's ability to target and anchor the biologically active polypeptide with high affinity and functional spatial orientation.

Engh's other significant patent involves "Amide derivatives of 3-phenyl-dihydropyrimido[4,5-d]pyrimidinones, their manufacture and use as pharmaceutical agents." This invention relates to novel amide derivatives of 3-phenyl dihydropyrimido[4,5-d]pyrimidinones, detailing a process for their manufacture, the medicaments containing them, and their use as pharmaceutically active agents. The derivatives are characterized as new compounds of a specific general formula.

Career Highlights

Throughout his career, Richard Engh has worked with prominent companies in the pharmaceutical industry, including Boehringer Mannheim GmbH and Roche Diagnostics GmbH. His experience in these organizations has contributed to his expertise in developing innovative pharmaceutical solutions.

Collaborations

Engh has collaborated with notable professionals in his field, including Erhard Kopetzki and Wolfram Bode. These collaborations have likely enhanced his research and development efforts, leading to his successful patent applications.

Conclusion

Richard Engh's contributions to biotechnology through his innovative patents demonstrate his commitment to advancing pharmaceutical science. His work continues to impact the industry positively, showcasing the importance of innovation in developing new therapeutic agents.